J Scherer

580 total citations
11 papers, 381 citations indexed

About

J Scherer is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, J Scherer has authored 11 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Oncology. Recurrent topics in J Scherer's work include Pancreatic and Hepatic Oncology Research (1 paper), Nausea and vomiting management (1 paper) and Neutropenia and Cancer Infections (1 paper). J Scherer is often cited by papers focused on Pancreatic and Hepatic Oncology Research (1 paper), Nausea and vomiting management (1 paper) and Neutropenia and Cancer Infections (1 paper). J Scherer collaborates with scholars based in Germany, United States and Switzerland. J Scherer's co-authors include C. S. Pitchumoni, Dhiraj Yadav, Vijay Singh, Theodore A. Stein, Leslie Wise, H. E. Myrvold, F. Müller‐Spahn, E. Rüther, Mário R. Louzã and DW Dodick and has published in prestigious journals such as Circulation, Journal of Hepatology and Annals of the Rheumatic Diseases.

In The Last Decade

J Scherer

10 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Scherer Germany 5 292 169 150 72 58 11 381
Alina Silaghi Romania 9 201 0.7× 281 1.7× 56 0.4× 124 1.7× 50 0.9× 13 511
H.-U. Klör Germany 7 287 1.0× 17 0.1× 120 0.8× 52 0.7× 83 1.4× 10 333
Sebastian Beer Germany 11 231 0.8× 59 0.3× 128 0.9× 82 1.1× 31 0.5× 20 387
Neda Valizadeh Iran 12 125 0.4× 46 0.3× 68 0.5× 33 0.5× 42 0.7× 34 319
Kazimierz Rembiasz Poland 15 376 1.3× 32 0.2× 80 0.5× 24 0.3× 60 1.0× 38 469
Claire K. Mulvey United States 11 65 0.2× 63 0.4× 94 0.6× 127 1.8× 53 0.9× 24 354
Walter Esposito Italy 5 100 0.3× 92 0.5× 88 0.6× 231 3.2× 90 1.6× 5 374
Metaxia Tampourlou Greece 9 174 0.6× 36 0.2× 50 0.3× 122 1.7× 249 4.3× 11 427
X. Jiang United States 6 138 0.5× 52 0.3× 52 0.3× 36 0.5× 102 1.8× 7 469
R Williams United Kingdom 10 303 1.0× 43 0.3× 111 0.7× 71 1.0× 13 0.2× 14 443

Countries citing papers authored by J Scherer

Since Specialization
Citations

This map shows the geographic impact of J Scherer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Scherer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Scherer more than expected).

Fields of papers citing papers by J Scherer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Scherer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Scherer. The network helps show where J Scherer may publish in the future.

Co-authorship network of co-authors of J Scherer

This figure shows the co-authorship network connecting the top 25 collaborators of J Scherer. A scholar is included among the top collaborators of J Scherer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Scherer. J Scherer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ferreira, António Jorge, et al.. (2024). Mortalidade por Transtorno Depressivo Recorrente: Uma Análise Sociodemográfica no Cenário Brasileiro. Brazilian Journal of Health Review. 7(9). e75398–e75398. 1 indexed citations
3.
Goadsby, Peter J., DW Dodick, Egilius L.H. Spierings, et al.. (2014). EHMTI-0178. CGRP monoclonal antibody LY2951742 for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study. The Journal of Headache and Pain. 15(S1). 7 indexed citations
4.
Scherer, J, Vijay Singh, C. S. Pitchumoni, & Dhiraj Yadav. (2013). Issues in Hypertriglyceridemic Pancreatitis. Journal of Clinical Gastroenterology. 48(3). 195–203. 323 indexed citations
5.
Sulkowski, Mark, et al.. (2012). 1209 IMPACT OF EARLY RESPONSE DEFINITIONS ON DURATION AND OUTCOME OF TREATMENT WITH BI201335 PLUS PR. Journal of Hepatology. 56. S479–S480. 1 indexed citations
6.
Werf, Frans Van de, et al.. (1998). Abciximab (Reopro) Achieves Effective Platelet Inhibition in St-Elevation MI: A TIMI 14 Substudy. Circulation. 98(17). 454. 1 indexed citations
7.
Pfeiffer, Herbert, et al.. (1997). P.1.094 Week two HAMD score predicts onset of action of TCA. European Neuropsychopharmacology. 7. S164–S165. 2 indexed citations
8.
Harrison, F., et al.. (1994). Study of pharmacokinetics and pharmacodynamics of two preparations of metoclopramide.. PubMed. 44(4). 519–21. 4 indexed citations
9.
Louzã, Mário R., F. Müller‐Spahn, E. Rüther, & J Scherer. (1988). Haloperidol Plasma Level after a Test Dose as Predictor for the Clinical Response to Treatment in Acute Schizophrenic Patients. Pharmacopsychiatry. 21(5). 226–231. 7 indexed citations
10.
Myrvold, H. E., et al.. (1984). The nipple valve as a sphincter substitute for the ileocecal valve: prevention of bacterial overgrowth in the small bowel.. PubMed. 96(1). 42–7. 33 indexed citations
11.
Scherer, J, et al.. (1967). [Importance of urinary and plasmatic concentrations of a chemotherapeutic agent in the treatment of urinary infections. Comparative study on 3 sulfonamides].. PubMed. 97(43). 1429–34. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026